ArticleDiabetes therapy : research, treatment and education of diabetes and related disorders2022

Concomitant iGlarLixi and Sodium-Glucose Co-transporter-2 Inhibitor Therapy in Adults with Type 2 Diabetes: LixiLan-G Trial and Real-World Evidence Results.

Cristian Guja et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.